Analysis of circulating nucleic acids in bodily fluids, also known as “liquid biopsy”, is a new and revolutionary development in the world of diagnostics and personalized medicine. Liquid biopsies have rapidly gained prominence with their potential to identify specific biomarkers with a non-invasive sample collection process, diminishing the need for expensive, high-risk, and painful tissue biopsies.
This white paper from Zymo Research outlines next-generation sequencing methods and considerations for liquid biopsy, including sample collection, cell-free DNA isolation, the advantages of epigenetic-based biomarkers, and profiling techniques.
Offered Free by: Zymo Research
See All Resources from: Zymo Research
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.